Measurement of Ceramide and Sphingolipid Metabolism in Tumors: Potential Modulation of Chemotherapy
Ceramide is a bioactive lipid involved in the induction of apoptosis and is the precursor to several sphingolipids, including sphingomyelin, the gangliosides, and sphingosine. Ceramide production is increased in response to stress and toxic agents. Because modulation of ceramide levels has been shown to affect sensitivity and/or resistance to therapeutic agents, it will be important to assess the activity of sphingolipid metabolic pathways when investigating the mode of action of antitumor drugs. This chapter summarizes protocols for quantitating the level of apoptosis, the activities of acidic sphingomyelinase, neutral sphingomyelinase, glycosylceramide synthase, sphingomyelin synthase, and ceramidase, and the amount of ceramide in tumor xenografts in nude mice.
- Assessment of Predictive Values of Tumor Markers
- Cancer Biology
- The Impact of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV): From Research to Clinical Practice
- Role of Receptor Tyrosine Kinases in Lung Cancer
- 以細胞為靶目標(biāo)的噬菌體肽篩選材料與方法
- Aberrant Crypt Foci in Colon Cancer Epidemiology
- The Use of Denaturing High Performance Liquid Chromatography (DHPLC) for Mutation Scanning of Hereditary Cancer Genes
- Photodynamic Therapy in Lung Cancer: A Review
- 基因細胞內(nèi)導(dǎo)入技術(shù)
- 蘇木素染料的配制